TH1701004487A -
Pharmaceutical components that contain N - (3,5-dimetoxyphenyl) - N '- (1 - methyl ethyl) - N - (3- (1 - methyl - 1h - pyrazol -4-il) Quinosalin-6-il] ethane-1, 2-diamine
- Google Patents
Pharmaceutical components that contain N - (3,5-dimetoxyphenyl) - N '- (1 - methyl ethyl) - N - (3- (1 - methyl - 1h - pyrazol -4-il) Quinosalin-6-il] ethane-1, 2-diamine
Info
Publication number
TH1701004487A
TH1701004487ATH1701004487ATH1701004487ATH1701004487ATH 1701004487 ATH1701004487 ATH 1701004487ATH 1701004487 ATH1701004487 ATH 1701004487ATH 1701004487 ATH1701004487 ATH 1701004487ATH 1701004487 ATH1701004487 ATH 1701004487A
: ข้อถือสิทธิ์ (ข้อที่หนึ่ง) ซึ่งจะปรากฏบนหน้าประกาศโฆษณา : แท็ก : สิทธิบัตรยา: Privilege (number one) that will appear on the advertisement page: Tag: drug patent
TH1701004487A2016-02-09
Pharmaceutical components that contain N - (3,5-dimetoxyphenyl) - N '- (1 - methyl ethyl) - N - (3- (1 - methyl - 1h - pyrazol -4-il) Quinosalin-6-il] ethane-1, 2-diamine
TH1701004487A
(en)
A new type of polymerization of N- (2- (6-fluoro-1H- ildole-3-il) ethyl] -3- (2,2,3,3, -tetrafluoropoxy Benzylamine hydrochloride for the treatment of Alzheimer's
Pharmaceutical components and therapeutic combinations containing substances Inhibits cholesterol-transmitted proteins and HMG CoA reductase inhibitors.
N- (4-hydroxy-4-methyl-cyclohexyl) -4-phenyl-benzene sulfonamide and N- (4-hydroxy-4- Methyl-cyclohexyl) -4- (2-pyridyl) benzene sulfonamides and their therapeutic use